These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20637914)

  • 1. Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate.
    Allen MR; Turek JJ; Phipps RJ; Burr DB
    Bone; 2011 Jul; 49(1):128-32. PubMed ID: 20637914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
    Allen MR; Iwata K; Phipps R; Burr DB
    Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats.
    Fuchs RK; Phipps RJ; Burr DB
    J Bone Miner Res; 2008 Oct; 23(10):1689-97. PubMed ID: 18466070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alendronate and risedronate on bone material properties in actively forming trabecular bone surfaces.
    Hofstetter B; Gamsjaeger S; Phipps RJ; Recker RR; Ebetino FH; Klaushofer K; Paschalis EP
    J Bone Miner Res; 2012 May; 27(5):995-1003. PubMed ID: 22336962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.
    Zikan V; Stepan JJ
    Bone; 2009 Apr; 44(4):634-8. PubMed ID: 19150421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.
    Mashiba T; Hirano T; Turner CH; Forwood MR; Johnston CC; Burr DB
    J Bone Miner Res; 2000 Apr; 15(4):613-20. PubMed ID: 10780852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures.
    Geoffroy V; Paschalis EP; Libouban H; Blouin S; Ostertag A; Chappard D; Cros M; Phipps R; de Vernejoul MC
    Calcif Tissue Int; 2011 Jun; 88(6):464-75. PubMed ID: 21455736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading.
    Follet H; Li J; Phipps RJ; Hui S; Condon K; Burr DB
    Bone; 2007 Apr; 40(4):1172-7. PubMed ID: 17240209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.
    Huuskonen J; Arnala I; Olkkonen H; Alhava E
    Ann Chir Gynaecol; 2001; 90(2):109-14. PubMed ID: 11459259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model.
    Nam SH; Jeong JH; Che X; Lim KE; Nam H; Park JS; Choi JY
    Bone; 2012 Jan; 50(1):149-55. PubMed ID: 22036912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
    Coxon FP; Thompson K; Roelofs AJ; Ebetino FH; Rogers MJ
    Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate.
    Gamsjaeger S; Buchinger B; Zoehrer R; Phipps R; Klaushofer K; Paschalis EP
    Bone; 2011 Dec; 49(6):1160-5. PubMed ID: 21893225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
    Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
    Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
    Ma YF; Lin BY; Jee WS; Lin CH; Chen YY; Ke HZ; Li XJ
    J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.
    Feher A; Koivunemi A; Koivunemi M; Fuchs RK; Burr DB; Phipps RJ; Reinwald S; Allen MR
    Bone; 2010 Jan; 46(1):203-7. PubMed ID: 19857619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate.
    Yano T; Yamada M; Inoue D
    Calcif Tissue Int; 2017 Jul; 101(1):102-110. PubMed ID: 28337514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study.
    Rosen CJ; Hochberg MC; Bonnick SL; McClung M; Miller P; Broy S; Kagan R; Chen E; Petruschke RA; Thompson DE; de Papp AE;
    J Bone Miner Res; 2005 Jan; 20(1):141-51. PubMed ID: 15619680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis.
    Ding M; Danielsen CC; Hvid I
    Calcif Tissue Int; 2008 Jan; 82(1):77-86. PubMed ID: 18175032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of denosumab, alendronate, or denosumab following alendronate on bone turnover, calcium homeostasis, bone mass and bone strength in ovariectomized cynomolgus monkeys.
    Kostenuik PJ; Smith SY; Samadfam R; Jolette J; Zhou L; Ominsky MS
    J Bone Miner Res; 2015 Apr; 30(4):657-69. PubMed ID: 25369992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body.
    Chevalier Y; Quek E; Borah B; Gross G; Stewart J; Lang T; Zysset P
    Bone; 2010 Jan; 46(1):41-8. PubMed ID: 19800436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.